Open | - |
Close | - |
Volume / Avg. | 0 / 539.345K |
Day Range | - - - |
52 Wk Range | 9.900 - 17.730 |
Market Cap | $1.200B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 9.09% |
Days to Cover | 8.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Deciphera Pharmaceuticals (NASDAQ: DCPH) through any online brokerage.
Other companies in Deciphera Pharmaceuticals’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).
The latest price target for Deciphera Pharmaceuticals (NASDAQ: DCPH) was reported by Stifel on Wednesday, February 7, 2024. The analyst firm set a price target for 23.00 expecting DCPH to rise to within 12 months (a possible 54.88% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Deciphera Pharmaceuticals (NASDAQ: DCPH) is $14.85 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.